JARED LAINO: Open Payments
NPI 1568981538 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,190 in 122 payments from 15 companies in 2025. Trend: 2023 $1,983 · 2024 $1,964 · 2025 $2,190
Food & beverage: $2,190
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $339 |
| Teva Pharmaceuticals USA, Inc. | 19 | $319 |
| Neurocrine BioSciences, Inc. | 16 | $313 |
| Otsuka America Pharmaceutical, Inc. | 9 | $265 |
| Alkermes, Inc. | 7 | $154 |
| Janssen Pharmaceuticals, Inc | 9 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $150 |
| Vanda Pharmaceuticals Inc. | 14 | $144 |
| E.R. Squibb & Sons, L.L.C. | 6 | $107 |
| Supernus Pharmaceuticals, Inc. | 5 | $93 |
Products named: VRAYLAR, INGREZZA, REXULTI, UZEDY, ARISTADA, CAPLYTA, SPRAVATO, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
